EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications

Paschalis Karakasis iD, Panagiotis Theofilis iD, Panayotis K Vlachakis iD, Nikias Milaras iD, Kallirhoe Kalinderi, Dimitrios Patoulias iD, Antonios P Antoniadis iD, Nikolaos Fragakis iD

Medical Sciences · 30.07.2025 · 13 (3) · 102

DOI: 10.3390/medsci13030102 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 30.07.2025. Verfasst von Paschalis Karakasis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Genetic Therapy, Arrhythmias, Cardiac. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac arrhythmias remain a major source of morbidity and mortality, often stemming from molecular and structural abnormalities that are insufficiently addressed by current pharmacologic and interventional therapies. Gene therapy has emerged as a transformative approach, offering precise and durable interventions that directly target the arrhythmogenic substrate. Across the spectrum of inherited and acquired arrhythmias—including long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, atrial fibrillation, and post-infarction ventricular tachycardia—gene-based strategies such as allele-specific silencing, gene replacement, CRISPR-mediated editing, and suppression-and-replacement constructs are showing growing translational potential. Advances in delivery platforms, including cardiotropic viral vectors, lipid nanoparticle-encapsulated mRNA, and non-viral reprogramming tools, have further enhanced the specificity and safety of these approaches. Additionally, innovative applications such as biological pacemaker development and mutation-agnostic therapies underscore the versatility of genetic modulation. Nonetheless, significant challenges remain, including vector tropism, immune responses, payload limitations, and the translational gap between preclinical models and human electrophysiology. Integration of patient-derived cardiomyocytes, computational simulations, and large-animal studies is expected to accelerate clinical translation. This review provides a comprehensive synthesis of the mechanistic rationale, therapeutic strategies, delivery platforms, and translational frontiers of gene therapy for cardiac arrhythmias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyArrhythmias, CardiacHumansAnimalsGenetic Vectors

Stichwörter der Autor:innen

atrial fibrillationcardiac arrhythmiasgene therapygenetic modulationgenome editingion channelopathiesventricular tachycardiaviral vectors

Autor:innen und Institutionen

  • Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
  • First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 15772 Athens, Greece.
  • Department of Biomedical Sciences, School of Health Sciences, International Hellenic University, 5400 Thessaloniki, Greece.
  • Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, 54124 Thessaloniki, Greece.

ORCID-Profile: Paschalis Karakasis, Panagiotis Theofilis, Panayotis K Vlachakis, Nikias Milaras, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis

Zitieren

APA

Karakasis, P., Theofilis, P., Vlachakis, P. K., Milaras, N., Kalinderi, K., Patoulias, D., Antoniadis, A. P., & Fragakis, N. (2025). Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications. Medical Sciences, 13(3), 102. https://doi.org/10.3390/medsci13030102

Vancouver

Karakasis P, Theofilis P, Vlachakis PK, Milaras N, Kalinderi K, Patoulias D, et al. Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications. Medical Sciences. 2025;13(3):102. doi:10.3390/medsci13030102

BibTeX
@article{Karakasis2025,
  author = {Karakasis, Paschalis and Theofilis, Panagiotis and Vlachakis, Panayotis K and Milaras, Nikias and Kalinderi, Kallirhoe and Patoulias, Dimitrios and Antoniadis, Antonios P and Fragakis, Nikolaos},
  title = {Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications},
  journal = {Medical Sciences},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {102},
  doi = {10.3390/medsci13030102}
}
Kostenlos starten →